OCT MSF Sweden office, Fredsborgsgatan 24, 117 43 Stockholm
Millions of lives are saved every year thanks to vaccines. Nevertheless, access to vaccines is still limited in large parts of the world. Challenges to vaccine access include suitability of vaccine products to local contexts, affordability of vaccines and strength of health systems.
Due to lack of competition in the pharmaceutical market, new vaccines such as pneumococcal conjugate vaccines that protect against pneumonia and rotavirus vaccines against childhood diarrhea are expensive. The high prices prevent many governments from making these vaccines generally available to their country’s children.
The lack of research and development into vaccines that are better suited for use in low- and middle income countries is another challenge, which is a consequence of the lack of economic incentives for the pharmaceutical industry.
This breakfast seminar will explore some of these challenges to improving immunisation and aims to stimulate a discussion on addressing these barriers so that all children can benefit from vaccination.
Register by e-mail to email@example.com.